The Anna Fuller Fund Grant

The Anna Fuller Fund Grant

Status: ACTIVE
Funder: The Anna Fuller Fund
Amount: US $75,000 - US $150,000
Last Updated: June 14, 2025

Summary

The Anna Fuller Fund Grant provides year-round support for organizations dedicated to alleviating suffering caused by cancer. Established in memory of Egbert C. Fuller’s wife, the fund prioritizes applications that focus on cancer research and education initiatives. Eligible applicants must be 501(c)(3) organizations or equivalent charities outside the U.S. Grant funds cannot be used for direct treatment, ensuring that resources are allocated to research and public education.

Overview

Note: Applications are accepted year-round. Applications must be submitted by July 31st to be reviewed at the annual grant meeting that occurs at the end of the year. About the Foundation The Anna Fuller Fund was created by Egbert C. Fuller in memory of his beloved wife who died from cancer. Egbert C. Fuller was a manufacturer of printing and bookbinding machinery. The Anna Fuller Fund Mission To provide grants to organizations that alleviate people's suffering from cancer through: Research as to its cause, treatment and care, and theEducation of the public as to its prevention and treatment.

Eligibility

You can learn more about this opportunity by visiting the funder's website. The foundation will primarily support grant requests that contribute to an applicant organization's specific cancer research project or initiative, as well as education programs for the prevention and treatment of cancer. Grant funds may support requests designated for a specific medical research scientific study.To be eligible, organizations must qualify as exempt organizations under Sections 501(c)(3) of the Internal Revenue Code or equivalent charitable organizations outside of the United States. Equivalent charitable organizations outside of the United States will require additional documentation and review.

Ineligibility

Grant funds cannot be used for the actual treatment of persons suffering with cancer except as incidental to cancer research and/or education.